Interest Expense in USD of GT Biopharma, Inc. from Q2 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
GT Biopharma, Inc. quarterly/annual Interest Expense history and change rate from Q2 2010 to 2023.
  • GT Biopharma, Inc. Interest Expense for the quarter ending 30 Jun 2023 was $1K.
  • GT Biopharma, Inc. annual Interest Expense for 2023 was $213K, a 2563% increase from 2022.
  • GT Biopharma, Inc. annual Interest Expense for 2022 was $8K, a 98.9% decline from 2021.
  • GT Biopharma, Inc. annual Interest Expense for 2021 was $718K.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Change (%)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Change (%)

GT Biopharma, Inc. Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $1K* 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2023
Q1 2023 $212K 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024
Q4 2021 $718K $22K +$9.25M 01 Oct 2021 31 Dec 2021 10-K 30 Mar 2023
Q3 2021 -$8.53M $0 -$931K -100% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2021
Q2 2021 -$7.6M $0 -$4.66M -100% 01 Apr 2021 30 Jun 2021 10-Q/A 29 Dec 2021
Q1 2021 -$2.95M $696K +$58K +9.09% 01 Jan 2021 31 Mar 2021 10-Q 17 May 2021
Q4 2020 -$3M -$9.23M -$5.61M -155% 01 Oct 2020 31 Dec 2020 10-K 16 Apr 2021
Q3 2020 $2.61M $931K +$371K +66.3% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021
Q2 2020 $2.24M $4.66M +$4.18M +872% 01 Apr 2020 30 Jun 2020 10-Q/A 29 Dec 2021
Q1 2020 -$1.94M $638K +$184K +40.5% 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021
Q4 2019 -$2.13M -$3.62M -$4.76M -418% 01 Oct 2019 31 Dec 2019 10-K 16 Apr 2021
Q3 2019 $2.63M $560K -$563K -50.1% 01 Jul 2019 30 Sep 2019 10-Q 13 Nov 2020
Q2 2019 $3.2M $479K -$3.45M -87.8% 01 Apr 2019 30 Jun 2019 10-Q/A 18 Aug 2020
Q1 2019 $6.64M $454K -$2.48M -84.5% 01 Jan 2019 31 Mar 2019 10-Q 15 May 2019
Q4 2018 $9.12M $1.14M +$1M +744% 01 Oct 2018 31 Dec 2018 10-K 27 Mar 2020
Q3 2018 $8.11M $1.12M -$2.65M -70.2% 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019
Q2 2018 $10.8M $3.92M +$2.75M +233% 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2019
Q1 2018 $8.01M $2.93M -$589K -16.7% 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019
Q4 2017 $8.6M $135K -$1.64M -92.4% 01 Oct 2017 31 Dec 2017 10-K 29 Mar 2019
Q3 2017 $10.2M $3.77M +$2.23M +145% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018
Q2 2017 $8.01M $1.18M -$421K -26.3% 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018
Q1 2017 $8.43M $3.52M +$1.87M +114% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018
Q4 2016 $6.56M $1.77M -$5.25M -74.8% 01 Oct 2016 31 Dec 2016 10-K 01 Mar 2018
Q3 2016 $11.8M $1.54M -$188K -10.9% 01 Jul 2016 30 Sep 2016 10-Q/A 28 Feb 2018
Q2 2016 $12M $1.6M +$750K +88.3% 01 Apr 2016 30 Jun 2016 10-Q/A 28 Feb 2018
Q1 2016 $11.2M $1.65M -$5.79M -77.9% 01 Jan 2016 31 Mar 2016 10-Q/A 28 Feb 2018
Q4 2015 $17M $7.03M +$5.51M +363% 01 Oct 2015 31 Dec 2015 10-K/A 28 Feb 2018
Q3 2015 $11.5M $1.72M -$1.54M -47.2% 01 Jul 2015 30 Sep 2015 10-Q/A 28 Feb 2018
Q2 2015 $13.1M $849K +$681K +405% 01 Apr 2015 30 Jun 2015 10-Q/A 28 Feb 2018
Q1 2015 $12.4M $7.44M +$7.24M +3676% 01 Jan 2015 31 Mar 2015 10-Q/A 28 Feb 2018
Q4 2014 $5.15M $1.52M +$1.28M +546% 01 Oct 2014 31 Dec 2014 10-K/A 28 Feb 2018
Q3 2014 $3.86M $3.26M +$3.05M +1418% 01 Jul 2014 30 Sep 2014 10-Q 13 Nov 2015
Q2 2014 $815K $168K -$47K -21.9% 01 Apr 2014 30 Jun 2014 10-Q 14 Aug 2015
Q1 2014 $862K $197K -$334K -62.9% 01 Jan 2014 31 Mar 2014 10-Q 14 May 2015
Q4 2013 $1.2M $235K -$113K -32.5% 01 Oct 2013 31 Dec 2013 10-K 31 Mar 2015
Q3 2013 $1.31M $215K +$150K +231% 01 Jul 2013 30 Sep 2013 10-Q 17 Dec 2014
Q2 2013 $1.16M $215K -$951K -81.6% 01 Apr 2013 30 Jun 2013 10-Q 08 Jan 2015
Q1 2013 $2.11M $531K +$457K +618% 01 Jan 2013 31 Mar 2013 10-Q 08 Jan 2015
Q4 2012 $1.65M $348K +$257K +282% 01 Oct 2012 31 Dec 2012 10-K 08 Jan 2015
Q3 2012 $1.4M $65K -$52K -44.4% 01 Jul 2012 30 Sep 2012 10-Q 17 Dec 2014
Q2 2012 $1.45M $1.17M +$986K +548% 01 Apr 2012 30 Jun 2012 10-Q 12 Dec 2014
Q1 2012 $462K $74K -$94K -56% 01 Jan 2012 31 Mar 2012 10-Q 10 Dec 2014
Q4 2011 $556K $91K 01 Oct 2011 31 Dec 2011 10-K 18 Nov 2014
Q3 2011 $117K +$140K 01 Jul 2011 30 Sep 2011 10-Q 21 Nov 2012
Q2 2011 $180K +$168K +1400% 01 Apr 2011 30 Jun 2011 10-Q/A 13 Sep 2012
Q1 2011 $168K 01 Jan 2011 31 Mar 2011 10-Q 21 May 2012
Q3 2010 -$23K 01 Jul 2010 30 Sep 2010 10-Q 21 Nov 2011
Q2 2010 $12K 01 Apr 2010 30 Jun 2010 10-Q/A 12 Sep 2011

GT Biopharma, Inc. Annual Interest Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $213K +$205K +2563% 01 Jan 2023 31 Dec 2023 10-K 26 Mar 2024
2022 $8K -$710K -98.9% 01 Jan 2022 31 Dec 2022 10-K 26 Mar 2024
2021 $718K +$3.72M 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023
2020 -$3M -$875K -41.1% 01 Jan 2020 31 Dec 2020 10-K 16 Apr 2021
2019 -$2.13M -$11.2M -123% 01 Jan 2019 31 Dec 2019 10-K 16 Apr 2021
2018 $9.12M +$515K +5.99% 01 Jan 2018 31 Dec 2018 10-K 27 Mar 2020
2017 $8.6M +$2.05M +31.2% 01 Jan 2017 31 Dec 2017 10-K 29 Mar 2019
2016 $6.56M -$10.5M -61.5% 01 Jan 2016 31 Dec 2016 10-K 01 Mar 2018
2015 $17M +$11.9M +231% 01 Jan 2015 31 Dec 2015 10-K/A 28 Feb 2018
2014 $5.15M +$3.95M +330% 01 Jan 2014 31 Dec 2014 10-K/A 28 Feb 2018
2013 $1.2M -$457K -27.6% 01 Jan 2013 31 Dec 2013 10-K 31 Mar 2015
2012 $1.65M +$1.1M +197% 01 Jan 2012 31 Dec 2012 10-K 08 Jan 2015
2011 $556K +$43K +8.38% 01 Jan 2011 31 Dec 2011 10-K 18 Nov 2014
2010 $513K 01 Jan 2010 31 Dec 2010 10-K 16 Apr 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.